» Articles » PMID: 28042237

Gut Microbiome, Surgical Complications and Probiotics

Overview
Specialty Gastroenterology
Date 2017 Jan 3
PMID 28042237
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

The trigger for infectious complications in patients following major abdominal operations is classically attributed to endogenous enteral bacterial translocation, due to the critical condition of the gut. Today, extensive gut microbiome analysis has enabled us to understand that almost all "evidence-based" surgical or medical intervention (antibiotics, bowel preparation, opioids, deprivation of nutrition), in addition to stress-released hormones, could affect the relative abundance and diversity of the enteral microbiome, allowing harmful bacteria to proliferate in the place of depressed beneficial species. Furthermore, these bacteria, after tight sensing of host stress and its consequent humoral alterations, can and do switch their virulence accordingly, towards invasion of the host. Probiotics are the exogenously given, beneficial clusters of live bacteria that, upon digestion, seem to succeed in partially restoring the distorted microbial diversity, thus reducing the infectious complications occurring in surgical and critically ill patients. This review presents the latest data on the interrelationship between the gut microbiome and the occurrence of complications after colon surgery, and the efficacy of probiotics as therapeutic instruments for changing the bacterial imbalance.

Citing Articles

Complex Probiotics Ameliorate Fecal Microbiota Transplantation-Induced IBS in Mice via Gut Microbiota and Metabolite Modulation.

Gao Y, Borjihan Q, Zhang W, Li L, Wang D, Bai L Nutrients. 2025; 17(5).

PMID: 40077671 PMC: 11902000. DOI: 10.3390/nu17050801.


Whole Genome Analysis of Limosilactobacillus fermentum MCC0552 for Probiotic Functionalities and Comparative Genomic Study with Reference Strains.

Komatwar K, Sundararaman A, Raphel S, Halami P Probiotics Antimicrob Proteins. 2025; .

PMID: 39971853 DOI: 10.1007/s12602-025-10467-9.


Unveiling the Interplay Between the Human Microbiome and Gastric Cancer: A Review of the Complex Relationships and Therapeutic Avenues.

Al-Matouq J, Al-Ghafli H, Alibrahim N, Alsaffar N, Radwan Z, Ali M Cancers (Basel). 2025; 17(2).

PMID: 39858007 PMC: 11763844. DOI: 10.3390/cancers17020226.


A Pilot Study of the Gut Microbiota in Spine Fusion Surgery Patients.

Cyphert E, Clare S, Dash A, Nixon J, Raphael J, Harrison J HSS J. 2025; 21(1):65-72.

PMID: 39846059 PMC: 11748416. DOI: 10.1177/15563316231201410.


Interaction of the Gut Microbiome With Cancer Treatment.

Barrenechea P J Adv Pract Oncol. 2024; 15(5):311-319.

PMID: 39328379 PMC: 11424160. DOI: 10.6004/jadpro.2024.15.5.3.


References
1.
Bo L, Li J, Tao T, Bai Y, Ye X, Hotchkiss R . Probiotics for preventing ventilator-associated pneumonia. Cochrane Database Syst Rev. 2014; (10):CD009066. PMC: 4283465. DOI: 10.1002/14651858.CD009066.pub2. View

2.
de La Cochetiere M, Durand T, Lepage P, Bourreille A, Galmiche J, Dore J . Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol. 2005; 43(11):5588-92. PMC: 1287787. DOI: 10.1128/JCM.43.11.5588-5592.2005. View

3.
Engel J, Balachandran P . Role of Pseudomonas aeruginosa type III effectors in disease. Curr Opin Microbiol. 2009; 12(1):61-6. DOI: 10.1016/j.mib.2008.12.007. View

4.
Jalanka J, Salonen A, Salojarvi J, Ritari J, Immonen O, Marciani L . Effects of bowel cleansing on the intestinal microbiota. Gut. 2014; 64(10):1562-8. DOI: 10.1136/gutjnl-2014-307240. View

5.
Alverdy J, Holbrook C, Rocha F, Seiden L, Wu R, Musch M . Gut-derived sepsis occurs when the right pathogen with the right virulence genes meets the right host: evidence for in vivo virulence expression in Pseudomonas aeruginosa. Ann Surg. 2000; 232(4):480-9. PMC: 1421180. DOI: 10.1097/00000658-200010000-00003. View